BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 85.71% | -8.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.12% | 0.58% | |||
| Operating Income | 19.12% | -0.58% | |||
| Income Before Tax | -250.49% | 115.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -250.52% | 115.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -250.52% | 115.66% | |||
| EBIT | 19.12% | -0.58% | |||
| EBITDA | 25.60% | -0.69% | |||
| EPS Basic | -356.94% | -59.49% | |||
| Normalized Basic EPS | -154.46% | 162.54% | |||
| EPS Diluted | -386.43% | 116.89% | |||
| Normalized Diluted EPS | -154.53% | 444.87% | |||
| Average Basic Shares Outstanding | 11.48% | 126.19% | |||
| Average Diluted Shares Outstanding | 11.33% | 8.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||